Viread tenofovir disoproxil fumarate: Additional Phase III data
Additional data from an open-label extension of the Phase III Study 103 trial in 201 patients with HBeAg-negative HBV
Gathering data...
Additional data from an open-label extension of the Phase III Study 103 trial in 201 patients with HBeAg-negative HBV